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Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses
potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with
ﬁbrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery.
Herein, we describe the cases of two pregnant women with parapneumonic empyema who were
successfully treated with intrapleural ﬁbrinolytic therapy.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license.Pneumonia and secondary complications such as pleural effu-
sion or empyema cause considerable morbidity and even mortality
in the general population. The ﬁrst-line therapy for complicated
parapneumonic effusion or empyema is drainage via chest tube or
catheter combined with antibiotic therapy. In patients with
empyema, if the ﬂuid and pus material becomes multiloculated
through the formation of ﬁbrin strands, tube drainage may be
inadequate and surgical treatment may be necessary. Enzymatic
debridement of the pleural cavity with ﬁbrinolytic agents is
a noninvasive option that can facilitate drainage and prevent the
need for surgery. Parapneumonic empyema during pregnancy is
diagnostically and therapeutically challenging. We describe the
cases of 2 pregnant women who developed pneumonia with
secondary pleural empyema and were successfully managed with
intrapleural ﬁbrinolytic therapy.
1. Case descriptions
Case 1. A 22-year-old woman in her 24th week of pregnancy
presented with a 15-day history of fever, pain in the lateral left
thorax, dyspnea, and productive cough. Physical examination
revealed diminished breath sounds and dullness on percussion of
the left chest. Obstetric sonography demonstrated a normal uterus
and fetus according to the gestational week. Chest x-ray showed, þ90 532 7732140 (mobile).
tas).
-NC-ND license.generalized opacity of the left hemithorax (Fig. 1). Computed
tomography of the chest revealed pneumothorax, ﬂuid collection,
and collapsed left lung (Fig. 2). The patient was hospitalized. A
chest tube was placed and 2000 mL of purulent ﬂuid were drained.
The status of the fetus was monitored daily by an obstetrician. After
chest tube drainage, repeat chest radiography revealed residual
ﬂuid but drainage through the thoracostomy tube had stopped.
After obstetric consultation, the decision was made to administer
ﬁbrinolytic therapy with streptokinase at a dose of 250,000 U/day
for 2 days. Each daily dose of streptokinase was diluted in 100 mL
saline solution and instilled in the pleural cavity via the chest tube,
which was then clamped for 4 h. After the 2 treatments, there was
a notable increase in the amount of ﬂuid that was draining. The
patient improved continuously thereafter. Her chest tube was
removed on day 12 of hospitalization, and she was discharged the
following day. The only remarkable ﬁnding on a chest x-ray taken
the day of discharge was normal (Fig. 3a,b). The patient carried her
pregnancy to term. She entered spontaneous labor after 39 weeks’
gestation and gave birth to a healthy female infant by vaginal
delivery. A follow-up chest x-ray at 2 months after discharge
showed complete resolution of the pneumonia and empyema.
Case 2. A 39-year-old woman in her 29th week of pregnancy
presented to hospital with a 15-day history of dyspnea, chest pain,
fever, and productive cough. Her chest x-ray showed a pleural
effusion in the right chest. The fetus’ condition was assessed by
ultrasound and found to be normal. Thoracocentesis revealed pus.
A chest tube was inserted and 700 mL of purulent ﬂuid were
Fig. 1. Chest radiography of patient at presentation.
Fig. 2. Computed tomography of the chest showing large left pleural effusion and
pneumothorax.
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amount of drainage was considered inadequate. Chest radiography
showed an organized ﬂuid collection in the right hemithorax and
consolidation and partial collapse of the lower lobe of the right lungFig. 3. a,b. Chest radiography of patient after(Fig. 4a,b). Thoracic magnetic resonance imaging demonstrated
elevation of the diaphragm, loculated pleural ﬂuid, and atelectasis
of the lower right lung lobe (Fig. 5a,b). Fibrinolytic therapy was
initiated, with 250,000 units streptokinase diluted in 100 ml saline
and instilled into the pleural cavity via the chest tube. The tube was
then clamped for 4 h. This treatment was repeated daily for the
next 3 days. A chest x-ray after the fourth day of enzymatic
debridement showed complete resolution of the pleural collection
and re-expansion of the lower right lung lobe (Fig. 6). By day 10 of
hospitalization, the drainage had reduced to less than 100 ml daily
and the chest tube was removed. After the patient was discharged,
her pregnancy continued uneventfully. At 40 weeks’ gestation, she
had a healthy child via uncomplicated vaginal delivery.2. Discussion
Pneumonia during pregnancy is uncommon but poses poten-
tially serious risks to both mother and fetus. It is estimated that at
least 40% of patients who are hospitalized with pneumonia develop
a parapneumonic effusion.1 There is considerable variation in the
clinical course of this condition. Pneumonia is complicated by
empyema in approximately 8% of all cases of pneumonia in preg-
nancy.2 The therapy for pneumonia with pleural effusion varies
depending on clinical circumstances. Conventional options include
antibiotic therapy alone for uncomplicated effusions, chest tube or
catheter drainage for complicated effusions, and surgical drainage
for organized empyema.
Intrapleural ﬁbrinolytic therapy is a therapeutic alternative for
managing complicated parapneumonic effusions. Although some
authors do not favor this form of treatment,3,4 others recommend
the instillation of ﬁbrinolytic drugs in addition to chest tube
drainage as a method to lyse ﬁbrous adhesions and enhance pleural
ﬂuid drainage, and to thus reduce surgical referrals.1,5 Speciﬁcally,
proponents of enzymatic debridement claim that if this therapy is
administered before pleural peel formation and lung entrapment, it
can avoid the need for surgical intervention.1,5
We found only one report in the English literature that exam-
ined the use of intrapleural ﬁbrinolytic therapy during pregnancy.6
However, other authors have documented successful intravascular
use of streptokinase during pregnancy for venous thromboembo-
lism without fetal teratogenicity, and with rare serious obstetric
complications or adverse effect.7,8 Turrentine et al. reviewed 172
cases of pregnant women with thromboembolic disease who weretreatment of intrapleural streptokinase.
Fig. 4. a. Chest radiography of patient at presentation; b. Chest radiography of patient after tube thoracostomy.
Fig. 5. a,b. Thoracic magnetic resonance imaging showing elevation of the diaphragm, loculated pleural ﬂuid and atelectasis.
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urokinase, 4 rt-PA).7 They reported 14 hemorrhagic complications
(8.1% of all cases), 10 fetal deaths (5.8%), 10 preterm deliveries
(5.8%), and 2 maternal deaths (1.2%). According to the authors,
these deaths were not related to the thrombolytic therapy. Tur-
rentine et al. and others have suggested that complications of
ﬁbrinolytic treatment are acceptable for this patient group
considering the gravity of conditions such as pulmonary
embolism.7,8Fig. 6. Chest radiography of patient after treatment of intrapleural streptokinase.In line with this, our opinion is that empyema and its surgical
therapy options expose a mother and fetus to greater risk than
ﬁbrinolytic therapy does. A 1998 study of the systemic ﬁbrinolytic
effects of intrapleural streptokinase in patients with complicated
parapneumonic pleural effusion or empyema showed no signiﬁcant
changes in systemic coagulation indices or status after adminis-
tration of this treatment.9 Maskell and coworkers investigated
intrapleural streptokinase therapy in 454 patients with pleural
infection and observed modest adverse events, such as chest pain,
fever, or allergic reaction.3 Rare occurrences of local and systemic
hemorrhage with intrapleural ﬁbrinolytic therapy have also been
documented.1,10
Nir et al. reported the case of a pregnant womanwith empyema
who was treated with intrapleural streptokinase instillation,6 the
same therapy as our 2 patients received. They suggested that this
method is safe and effective for managing parapneumonic
empyema during pregnancy.
In conclusion, several days of streptokinase instillation into the
pleural cavity combined with chest tube drainage may be a rela-
tively safe alternative to surgical treatment of empyema during
pregnancy. Currently, there is insufﬁcient evidence regarding any
risks that ﬁbrinolytic therapy may pose to pregnant mothers and
their fetuses; however, we believe that it is not justiﬁed towithhold
ﬁbrinolytic therapy from pregnant patients if effective noninvasive
alternatives are lacking and this approach can avoid surgical
intervention.
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